Prestige Consumer Healthcare Inc. (NYSE:PBH) Shares Sold by Rice Hall James & Associates LLC

Rice Hall James & Associates LLC reduced its stake in Prestige Consumer Healthcare Inc. (NYSE:PBH - Free Report) by 3.2% during the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission. The fund owned 573,534 shares of the company's stock after selling 18,723 shares during the quarter. Prestige Consumer Healthcare accounts for 2.2% of Rice Hall James & Associates LLC's investment portfolio, making the stock its 8th biggest holding. Rice Hall James & Associates LLC owned about 1.16% of Prestige Consumer Healthcare worth $41,352,000 as of its most recent filing with the Securities and Exchange Commission.

Other institutional investors have also modified their holdings of the company. First Trust Direct Indexing L.P. grew its position in Prestige Consumer Healthcare by 18.5% in the 1st quarter. First Trust Direct Indexing L.P. now owns 4,422 shares of the company's stock valued at $321,000 after buying an additional 689 shares during the last quarter. Norden Group LLC boosted its holdings in shares of Prestige Consumer Healthcare by 40.6% in the first quarter. Norden Group LLC now owns 9,876 shares of the company's stock valued at $717,000 after acquiring an additional 2,852 shares in the last quarter. Diversify Advisory Services LLC acquired a new position in shares of Prestige Consumer Healthcare during the first quarter worth about $419,000. Mirae Asset Global Investments Co. Ltd. raised its holdings in Prestige Consumer Healthcare by 6.2% during the first quarter. Mirae Asset Global Investments Co. Ltd. now owns 26,579 shares of the company's stock worth $1,929,000 after purchasing an additional 1,543 shares in the last quarter. Finally, BNP Paribas Financial Markets raised its holdings in Prestige Consumer Healthcare by 143.4% during the first quarter. BNP Paribas Financial Markets now owns 51,246 shares of the company's stock worth $3,718,000 after purchasing an additional 30,191 shares in the last quarter. Institutional investors and hedge funds own 99.95% of the company's stock.

Prestige Consumer Healthcare Price Performance

Shares of PBH traded up $0.30 on Friday, reaching $74.05. The stock had a trading volume of 260,044 shares, compared to its average volume of 245,752. Prestige Consumer Healthcare Inc. has a twelve month low of $56.61 and a twelve month high of $75.80. The firm has a market capitalization of $3.67 billion, a PE ratio of 18.11, a PEG ratio of 2.08 and a beta of 0.47. The firm has a 50-day moving average of $72.17 and a 200 day moving average of $69.56. The company has a quick ratio of 1.90, a current ratio of 3.23 and a debt-to-equity ratio of 0.65.

Prestige Consumer Healthcare (NYSE:PBH - Get Free Report) last released its quarterly earnings results on Thursday, August 8th. The company reported $0.90 EPS for the quarter, beating the consensus estimate of $0.86 by $0.04. Prestige Consumer Healthcare had a net margin of 18.43% and a return on equity of 12.55%. The business had revenue of $267.10 million for the quarter, compared to analyst estimates of $260.54 million. During the same period in the prior year, the business earned $1.06 earnings per share. The company's quarterly revenue was down 4.4% on a year-over-year basis. Sell-side analysts expect that Prestige Consumer Healthcare Inc. will post 4.43 EPS for the current year.

Analyst Upgrades and Downgrades

Several equities analysts have issued reports on PBH shares. Jefferies Financial Group reiterated a "hold" rating and set a $76.00 target price (up previously from $70.00) on shares of Prestige Consumer Healthcare in a research report on Tuesday, September 24th. DA Davidson upped their price objective on Prestige Consumer Healthcare from $93.00 to $95.00 and gave the stock a "buy" rating in a report on Wednesday, August 28th. Two equities research analysts have rated the stock with a hold rating and four have issued a buy rating to the company. According to MarketBeat, the stock currently has a consensus rating of "Moderate Buy" and an average target price of $94.20.

About Prestige Consumer Healthcare

Prestige Consumer Healthcare Inc, together with its subsidiaries, develops, manufactures, markets, distributes, and sells over-the-counter (OTC) health and personal care products in the United States and internationally. The company operates in two segments, North American OTC Healthcare and International OTC Healthcare.